Tissue-Based Biomarkers for the Risk Stratification of Men With Clinically Localized Prostate Cancer

Tissue-Based Biomarkers for the Risk Stratification of Men With Clinically Localized Prostate Cancer

Risk stratification of men with clinically localized prostate cancer has historically relied on basic clinicopathologic parameters such as prostate specific antigen level, grade group, and clinical stage. However, prostate cancer often behaves in ways that cannot be accurately predicted by these par...

Full description

Bibliographic Details
Main Authors: Spyridon P. Basourakos, Michael Tzeng, Patrick J. Lewicki, Krishnan Patel, Bashir Al Hussein Al Awamlh, Siv Venkat, Jonathan E. Shoag, Michael A. Gorin, Christopher E. Barbieri, Jim C. Hu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
prostate cancer
tissue biomarker
prognosis
genetic marker
decision making
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.676716/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.676716/full

Similar Items